KALA BIO Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 71.1%.

Top 25 shareholders own 55.78% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
19.4%	Baker Bros. Advisors LP	891,335	US$5.8m	0%	0.05%
9.63%	SR One Capital Management, LP	443,661	US$2.9m	0%	0.54%
6.64%	ADAR1 Capital Management, LLC	306,067	US$2.0m	0%	0.35%
3.66%	Lagunita Biosciences	168,454	US$1.1m	0%	no data
3.53%	UBS O'Connor LLC	162,663	US$1.1m	10.2%	0.09%
3.05%	Millennium Management LLC	140,731	US$921.8k	-1.09%	no data
2.35%	Longitude Capital Management Co., LLC	108,239	US$709.0k	0%	0.12%
1.57%	Mark Iwicki	72,451	US$474.6k	0%	no data
1.16%	The Vanguard Group, Inc.	53,570	US$350.9k	6.53%	no data
0.81%	Geode Capital Management, LLC	37,116	US$243.1k	96.5%	no data
0.54%	R. Brazzell	24,689	US$161.7k	0%	no data
0.49%	Todd Bazemore	22,385	US$146.6k	0%	no data
0.48%	Darius Kharabi	22,154	US$145.1k	0%	no data
0.47%	Renaissance Technologies LLC	21,473	US$140.6k	0%	no data
0.46%	BlackRock, Inc.	21,356	US$139.9k	0%	no data
0.46%	Stanford Management Company	21,127	US$138.4k	0%	0.01%
0.35%	Mary Reumuth	16,056	US$105.2k	0%	no data
0.3%	Two Sigma Investments, LP	14,005	US$91.7k	0%	no data
0.17%	Mark Blumenkranz	7,752	US$50.8k	0%	no data
0.085%	Eric Trachtenberg	3,917	US$25.7k	0%	no data
0.066%	Andrew Koven	3,058	US$20.0k	0%	no data
0.065%	Howard Rosen	3,012	US$19.7k	0%	no data
0.051%	Gregory Perry	2,369	US$15.5k	0%	no data
0.029%	Charles Myers	1,321	US$8.7k	0%	no data
0.024%	Marjan Farid	1,100	US$7.2k	0%	no data